72 related articles for article (PubMed ID: 37182335)
1. Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.
Xiong J; Pecchi VG; Qui M; Ivanov AA; Mo X; Niu Q; Chen X; Fu H; Du Y
Assay Drug Dev Technol; 2018; 16(2):96-106. PubMed ID: 29634317
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
[TBL] [Abstract][Full Text] [Related]
3. Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase.
Rathert P
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440470
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs.
Piao L; Gao Y; Xu X; Su Y; Wang YD; Zhou J; Gao Y; Fang J; Li Q; Chang S; Kong R
Eur J Med Chem; 2024 Mar; 268():116264. PubMed ID: 38412693
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into the C-terminus of the histone-lysine N-methyltransferase NSD3 by small-angle X-ray scattering.
Belviso BD; Shen Y; Carrozzini B; Morishita M; di Luccio E; Caliandro R
Front Mol Biosci; 2024; 11():1191246. PubMed ID: 38516186
[TBL] [Abstract][Full Text] [Related]
6. The PWWP domain of the human oncogene WHSC1L1/NSD3 induces a metabolic shift toward fermentation.
Rona GB; Almeida DSG; Pinheiro AS; Eleutherio ECA
Oncotarget; 2017 Aug; 8(33):54068-54081. PubMed ID: 28903324
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome analysis in osteosarcoma to identify a personalized therapy.
Chiappetta C; Mancini M; Lessi F; Aretini P; De Gregorio V; Puggioni C; Carletti R; Petrozza V; Civita P; Franceschi S; Naccarato AG; Rocca CD; Mazzanti CM; Di Cristofano C
Oncotarget; 2017 Oct; 8(46):80416-80428. PubMed ID: 29113313
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin prodrug-based nanomedicines for the treatment of cancer.
Zhao H; Yu J; Zhang R; Chen P; Jiang H; Yu W
Eur J Med Chem; 2023 Oct; 258():115612. PubMed ID: 37441851
[TBL] [Abstract][Full Text] [Related]
9. Azaindole derivatives as potential kinase inhibitors and their SARs elucidation.
Fang G; Chen H; Cheng Z; Tang Z; Wan Y
Eur J Med Chem; 2023 Oct; 258():115621. PubMed ID: 37423125
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity.
Ishii T; Kobayakawa T; Matsuda K; Tsuji K; Ohashi N; Nakahata S; Noborio A; Yoshimura K; Mitsuya H; Maeda K; Tamamura H
Eur J Med Chem; 2023 Aug; 256():115449. PubMed ID: 37224601
[TBL] [Abstract][Full Text] [Related]
11. Structure-based discovery of IHMT-IDH1-053 as a potent irreversible IDH1 mutant selective inhibitor.
Liang Q; Wang B; Zou F; Guo G; Wang W; Wang W; Liu Q; Shen L; Hu C; Wang W; Wang A; Huang T; He Y; Xia R; Ge J; Liu J; Liu Q
Eur J Med Chem; 2023 Aug; 256():115411. PubMed ID: 37209613
[TBL] [Abstract][Full Text] [Related]
12. Oncogene alterations in non-small cell lung cancer with
Kitai H; Ebi H
Transl Lung Cancer Res; 2024 Mar; 13(3):684-688. PubMed ID: 38601453
[No Abstract] [Full Text] [Related]
13. Omics Technologies Improving Breast Cancer Research and Diagnostics.
Orsini A; Diquigiovanni C; Bonora E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628869
[TBL] [Abstract][Full Text] [Related]
14. NSD3: Advances in cancer therapeutic potential and inhibitors research.
Xiu S; Chi X; Jia Z; Shi C; Zhang X; Li Q; Gao T; Zhang L; Liu Z
Eur J Med Chem; 2023 Aug; 256():115440. PubMed ID: 37182335
[TBL] [Abstract][Full Text] [Related]
15. Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
Liu Z; Piao L; Zhuang M; Qiu X; Xu X; Zhang D; Liu M; Ren D
Oncol Rep; 2017 Nov; 38(5):2796-2802. PubMed ID: 28901481
[TBL] [Abstract][Full Text] [Related]
16. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
[TBL] [Abstract][Full Text] [Related]
17. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract][Full Text] [Related]
18. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
